Chinese Biotech Firm Brags It’s Making Money “Screening Out” Babies With Down Syndrome

China Abortion Down Syndrome Entertainment Eugenics Facebook International LifeNews Medical Press

Chinese Biotech Firm Brags It’s Making Money “Screening Out” Babies With Down Syndrome

A Chinese biotech firm has declared “screening out” babies with Down’s syndrome is a “cash cow” funding the growth of the whole business. The admission comes from a spokesperson for BGI Group – a Chinese genetics conglomerate whose main business is offering non-invasive prenatal tests, primarily used to diagnose Down’s syndrome.